ROCALTROL
LOE Approachingcalcitriol
NDAORALCAPSULEPriority Review
Approved
Aug 1978
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
9
Mechanism of Action
Pharmacologic Class:
Vitamin D3 Analog
Clinical Trials (5)
Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis
Started Sep 2023
300 enrolled
Low Bone Mineral DensityPostmenopausal Osteoporosis
A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients
Started May 2012
65 enrolled
Moderate to Severe Secondary HyperparathyroidismStage 5 Chronic Kidney Diseases
The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers
Started Jun 2009
41 enrolled
Healthy
Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
Started Feb 2009
110 enrolled
Secondary HyperparathyroidismChronic Kidney Disease
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
Started Jan 2009
13 enrolled
Secondary HyperparathyroidismDialysis